Özlem Aytaç

Dr. Özlem Aytaç

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 January 2025 in Engineering Applications of Artificial Intelligence
Verified
Journal Article
Closed access
ÖAÖzlem Aytaç
Özlem Aytaç
FSFeray Ferda Senol
Feray Ferda Senol
ITIlknur Tuncer
Ilknur Tuncer
Sengul DoganSengul Dogan
Sengul Dogan
TTTurker Tuncer
Turker Tuncer

30 April 2024 in Northwestern Medical Journal
Verified
Journal Article
Open access
PDF file
ÖAÖzlem Aytaç
Özlem Aytaç
Aim: Our study aimed to determine the antibiotic resistance rates of K. pneumoniae by retrospectively examining the results of urine culture samples studied in our laboratory. Methods: Urine samples with K. pneumoniae growth, sent to our laboratory from various wards, outpatient clinics, and intensive care units between July 1, 2018 and December 31, 2022 were included in the study and retrospectively examined. Results: The antibiotic to which K. pneumoniae was most resistant was cefixime (53.3%), and the antibiotic to which it was least resistant was imipenem (12.1%). While the lowest resistance rates were observed in the samples of outpatients, the highest resistance rates were observed in the samples of ward patients and to cefixime (81%), amoxicillin clavulanic acid (AMC) (80%), trimethoprim-sulfamethoxazole (TMT/SXT) (74.8%), and ciprofloxacin (72.1%). Ertapenem (48.9%), meropenem (50.2%) and piperacillin-tazobactam (PRP) (57.3%) resistance was found to be higher in intensive care patients. Conclusion: Although fluctuations in resistance rates have been observed over the years, resistance rates have generally been found to be high for antibiotics frequently used in the empirical treatment of urinary tract infections. Re-adjusting treatment according to culture results and keeping resistance rates in mind for empirical treatment will be important for treatment success.

15 March 2022 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
PDF file
FŞFeray Ferda Şenol
Feray Ferda Şenol
İBİlkay Bahçeci
İlkay Bahçeci
NANuray Arslan
Nuray Arslan
ÖAÖzlem Aytaç
Özlem Aytaç
PÖPinar Öner
Pinar Öner
ZTZülal Aşci Toraman
Zülal Aşci Toraman
Objective: It is aimed to compare the respiratory tract agents and antibiotic resistance rates in patients with a diagnosis of COVID-19 with the non-COVID-19 period. Material and Method: Patients diagnosed with bacterial respiratory tract infection between March 2019 and March 2021 were included in the study. Bacteria identification and antibiotic susceptibility were evaluated according to automated system and EUCAST standards. Results: Between March 2019-March 2020 (before the pandemic), the most common bacterium was Pseudomonas aeruginosa (P. aeruginosa) 280 (15.5%) second Acinetobacter baumannii (A. baumannii) in a total of 1797 patients hospitalized in the service and intensive care units, and the resistance rates were the same. Between March 2020 and 2021, a total of 1357 COVID -19 patients were found in clinical and intensive care units, and the most common reproducing agent was A. baumannii 168 (12.3%), the second P. aeruginosa 164, and resistance rates were found to invrease. Conclusion: The increase in the resistance rates of bacteria causing respiratory tract infection was remarkable. It was determined that P. aeruginosa and A. baumannii, which were the most common isolates before the pandemic and showed high resistance rates against all antibiotic groups, were the most common bacteria during the pandemic period.

8 March 2025 in Pathogens
Verified
Journal Article
Open access
PDF file
ÖAÖzlem Aytaç
Özlem Aytaç
ETElif Seren Tanriverdi
Elif Seren Tanriverdi
ÖGÖmür Gündağ
Ömür Gündağ
FŞFeray Ferda Şenol
Feray Ferda Şenol
GKGülden Eser Karlıdağ
Gülden Eser Karlıdağ
BOBarış Otlu
Barış Otlu
Background: We report a hospital outbreak caused by Burkholderia cepacia that occurred in 16 patients admitted to intensive care units in Elazığ, Türkiye, between 19 March and 23 April 2024. Methods: The outbreak investigation was initiated on 23 March 2024, four days after B. cepacia was detected in four different patients. Environmental samples were collected from various parts of the hospital to find the source of the outbreak. Arbitrarily Primed Polymerase Chain Reaction (AP-PCR) was performed to determine the genetic relationship between environmental and patient samples. Results: In total, 16 of 18 B. cepacia isolates were obtained from tracheal aspirate culture. A total of 10 of 16 patients developed hospital-acquired pneumonia due to B. cepacia. Among the environmental cultures in the intensive care units, only the respirator bacterial filter grew. The isolate obtained here was in the same cluster as the isolate obtained from patient samples, resulting in a dominant clustering rate of 94.4%. Conclusions: Improper and inappropriate use of respirators and equipment can lead to outbreaks. Early detection of the outbreak, identification of the source, and taking appropriate measures quickly to contain the outbreak are key.

27 November 2023 in Medicina
Verified
Journal Article
Open access
PDF file
FŞFeray Ferda Şenol
Feray Ferda Şenol
ETElif Seren Tanriverdi
Elif Seren Tanriverdi
ÖAÖzlem Aytaç
Özlem Aytaç
ZTZulal Aşçı Toraman
Zulal Aşçı Toraman
BOBarış Otlu
Barış Otlu
Background and Objectives: Vancomisin-resistant Enterococci (VRE), is a resistant microorganism that colonizes and causes infections in hospitalized patients. The aim of this study was to show the spread of vancomycin-resistant Enterococcus faecium (VREfm) step-by-step in all intensive care units, which started with the growth of VREfm on 2 December 2021 in the blood culture of a patient hospitalized in the anesthesia intensive care unit of our hospital and was found to have reached epidemic size in the surveys. Materials and Methods: Rectal swab samples were taken from all patients hospitalized in intensive care units, VRE colonization was determined, the VanA and VanB resistance genes associated with the vancomycin resistance of VREfm isolates were determined by PCR method, and clonal association analysis was performed by Arbitrarily Primed-PCR (AP-PCR) and PFGE (pulsed-field gel electrophoresis). Results: In our study, VRE were detected in 61 of 2601 rectal swab samples. In total, fifty-four (85.52%) of the VRE isolates were Enterococcus faecium, three (4.91%) was Enterococcus faecalis, three (4.91%) was Enterococcus gallinorum, and one (1.63%) was Enterococcus casseliflavus. It was determined that all of the 54 VREfm isolates, which were the most detected among all VRE isolates, carried the vanA gene. In the clonal association analysis of the isolates by AP-PCR and PFGE methods, it was found that they had 12 different genotypes, 48 of them were included in any cluster, the clustering rate was 88.8%, and the largest cluster was the genotype 1 cluster, with 36 isolates. Of the 54 patients with VREfm isolated recently, 18.51 percent of the clinical samples were isolated before the survey, and 9.25% were isolated after the survey. It was determined that 100% of VREfm isolates were resistant to ampicillin, levofloxacin, ciprofloxacin, high-level gentamicin, trimethoprimsulfamethoxazole, and teicoplanin, 7.4% to tigecycline, and 1.85% to linezolid. Conclusions: In our study, in the clonal association analysis performed by isolating VREfm in rectal swab samples, it was found that 88.8% of the samples were indistinguishably similar, and that the increase in the number of VREfm infections after the index case in our hospital was associated with the epidemic. VREfm infections cause long-term hospitalization, costs and also deaths, which shows the seriousness of the event, and the importance of the combination of epidemiological and molecular analysis in epidemic research.

22 December 2021 in TURKISH JOURNAL of CLINICS and LABORATORY
Verified
Journal Article
Open access
PDF file
FŞFeray Ferda Şenol
Feray Ferda Şenol
İBİlkay Bahçeci
İlkay Bahçeci
ÖAÖzlem Aytaç
Özlem Aytaç
PÖPinar Öner
Pinar Öner
ZTZülal Aşci Toraman
Zülal Aşci Toraman
Amaç: Genişlemiş Spektrumlu Beta Laktamaz (GSBL) pozitif mikroorganizmaların neden olduğu enfeksiyonların tedavisindeki zorluklar günümüzde en önemli sağlık sorunlarından biridir. çeşitli bakteriyolojik kültürlerinden izole edilen Gram negatif GSBL pozitif bakterilerin örnek türüne göre ampirik ve semptomatik tedaviye etkili antibiyotiklerin belirlenmesi amaçlanmıştır. Gereç Ve Yöntem: Bu çalışma 1 Ağustos 2019-1 Şubat 2020 tarihleri arasında çeşitli servis ve polikliniklerden rutin mikrobiyoloji laboratuvarına yollanan idrar, kan, yara, balgam, eklem sıvısı, plevral sıvı örneklerinden izole edilen bakteriyel etkenler ve antimikrobiyal duyarlılıkların retrospektif araştırılması ile yapılmıştır. Gram negatif GSBL pozitif bakterilerin tanımlanmaları ve antibiyotik duyarlılık testleri konvansiyonel yöntem ve MicroScan (Beckman Coultre, USA ) otomatize sistem ile yapılmıştır. Bulgular: Laboratuvara gönderilen 13,968 klinik örnekten izole edilen 1735 Gram negatif bakterinin 1041 (%60)’i GSBL pozitif idi. 1041 örneğin; 901 (%86,55)’i idrar, 47 (%4,51)’si Trakeal aspirat, 35 (%3,36)’i yara idi. GSBL pozitif bakterilerin en sık izole edilenleri 732(%70,3) ile Escherichia coli, 249(%23,9)’u Klebsiella pneumonia, 22(%2,11)’si Proteus mirabilis oluşturmaktaydı. Bu bakterilerin tamamı ampisilin, ampisilin-sulbaktam ve sefalosporin grubu antibiyotiklere dirençli iken bakterilerin en duyarlı olduğu grup ise karbapenem grubu antibiyotikler idi. Sonuç: Gram negatif bakterilerde, antibiyotiklere dirençli izole edilen suşların oranlarındaki artış, kullanılabilecek tedavi seçeneklerini oldukça kısıtlamaktadır. Özellikle çoklu antibiyotik dirençli, sıklıkla toplum ve hastane kökenli enfeksiyonlara neden olan Gram negatif GSBL pozitif bakterilerin antibiyotik direnç durumlarının belirlenmesi güncel direnç oranını ortaya çıkaracağı gibi tedavi başarısının artırılmasında yardımcı olacaktır. Her kurum kendi antibiyotik direncini saptayarak ülke verilerine katkı sunmalıdır.